Last updated: June 16, 2023
Sponsor: Taipei Veterans General Hospital, Taiwan
Overall Status: Active - Recruiting
Phase
N/A
Condition
Frozen Shoulder (Adhesive Capsulitis)
Bursitis
Treatment
normal saline
lidocaine hydrochloride
Triamcinolone Acetonide
Clinical Study ID
NCT05861570
2022-01-001B
Ages 35-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- age 35-65 years
- onset of shoulder stiffness since over a month
- limitation in the passive range of motion (ROM) over 30° when compared with thecontralateral side in at least two of these three movements: forward flexion,abduction, or external rotation.
Exclusion
Exclusion Criteria:
- ultrasound findings of rotator cuff tears,
- plain radiography findings of significant glenohumeral joint arthritis,
- accompanying cervical radiculopathy,
- systemic inflammatory joint disease,
- intraarticular injection into the glenohumeral joint within the past 3 months
- history of surgery on the affected shoulders,
- regular use of systemic non-steroidal anti-inflammatory drugs or corticosteroids,
- allergy to corticosteroid or lidocaine.
Study Design
Total Participants: 84
Treatment Group(s): 4
Primary Treatment: normal saline
Phase:
Study Start date:
May 18, 2023
Estimated Completion Date:
April 06, 2024
Study Description
Connect with a study center
Taipei Veterans General Hospital
Taipei City, 11217
TaiwanActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.